Title of Invention: Avermectin and avermectin monosaccharide derivatives substituted in the 4"-or 4'-position having pesticidal properties Abstract: What is described are a compound of the formula (I) Wherein U is —N(R2)OR3 or —N+(O−)═C(RE)RZ); n is 0 or 1; X—Y is —CH═CH— or —CH2—CH2—; R1 is C1-C12alkyl, C3-C8cycloalkyl or C2-C12alkenyl; R2 and R3 are, for example; independently from each other, -Q, —C(═O)-Z-Q or —CN; RZ and RE are, independently from each other, -Q, —C(═O)-Z-Q or —CN; or RZ and RE together are a three- to seven membered alkylene or alkenylene bridge, which is unsubstituted or mono- to tri-substituted; Z is a bond, O or —NR4—; Q is H, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C12-Cycloalkyl, C5-C12-cycloalkenyl, aryl, or heterocyclyl, which are unsubstituted or mono- to pentasubstituted; R4 is for example H, C1-C8alkyl, hydroxy-C1-C8alkyl, C3-C8cycloalkyl or C2-C8alkenyl; or, if appropriate, an E/Z isomer, E/Z isomer mixture and/or tautomer thereof; a process for preparing these compounds, their isomers and tautomers and the use of these compounds, their isomers and tautomers; pesticidal compositions whose active compound is selected from these compounds and their tautomers; intermediates for the preparation of the said compounds of the formula (I), methods for the preparation of the compounds of the formula (I), and a method for controlling pests using these compositions. Detailed Description: The invention relates (1) to compound of the formula wherein U is —N(R2)OR3 or —N+(O−)═C(RE)RZ); n is 0 or 1; X—Y is —CH═CH— or —CH2—CH2—; R1 is C1-C12alkyl, C3-C8cycloalkyl or C2-C12alkenyl; R2 and R3 are, independently from each other, -Q, —C(═O)-Z-Q or —CN; or R2 and R3 together are a three- to seven membered alkylene or alkenylene bridge, which is unsubstituted or mono to tri-substituted; RZ and RE are, independently from each other, -Q, —C(═O)-Z-Q or —CN; or RZ and RE together are a three- to seven membered alkylene or alkenylene bridge, which is unsubstituted or mono to tri-substituted; Z is a bond, O or —NR4—; R4 is H, C1-C8alkyl, hydroxy-C1-C8alkyl, C3-C8cycloalkyl, C2-C8alkenyl, C2-C8alkynyl, phenyl, benzyl —C(═O)R5, or —CH2—C(═O)—R5; Q is H, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C12-cycloalkyl, C5-C12-cycloalkenyl, aryl, or heterocyclyl, which are unsubstituted or mono- to pentasubstituted; wherein the alkyl-, alkenyl-, alkynyl-, alkylene-, alkenylene-, cycloalkyl-, cycloalkenyl-, aryl- and heterocyclyl-radicals of the substituents Q, R2, R3, R4, RZ, RE and Q are independently of each other selected from the group consisting of OH, ═O, SH, ═S, halogen, CN, —N3, SCN, NO2, Si(C1-C8alkyl)3, halo-C1-C2alkyl, C1-C12alkoxy-C1-C12alkoxy, C1-C12haloalkoxy, C3-C8cycloalkoxy, C2-C12alkenyloxy, C2-C12haloalkenyloxy, C2-C12haloalkenyl, C3-C12alkynyloxy, C2-C12haloalkynyl, C3-C12haloalkynyloxy, C2-C12alkenylthio, C2-C12halo-alkenylthio, C2-C12alkenylsulfinyl, C2-C12haloalkenylsulfinyl, C2-C12alkenylsulfonyl, C2-C12haloalkenylsulfonyl, C3-C8cycloalkyl which is unsubstituted or substituted by one to three methyl groups, norbornylenyl, C3-C8halocycloalkyl, C1-C12alkoxy, C3-C8cycloalkoxy, C1-C12alkylthio, C3-C8cycloalkylthio, C1-C12haloalkylthio, C1-C12alkyl-sulfinyl, C3-C8cyclo-alkylsulfinyl, C1-C12haloalkylsulfinyl, C3-C8halocycloalkylsulfinyl, C1-C12alkylsulfonyl, C3-C8cycloalkylsulfonyl, C1-C12haloalkylsulfonyl, C3-C8halocycloalkylsulfonyl, C2-C8alkenyl, C2-C8alkynyl, —N(R8)2 wherein the two R8 are independent of each other, —C(═O)R5, —O—C(═O)R6, —NHC(═O)R5, —S—C(═S)R6, —P(═O)(OC1—C6alkyl)2, —S(═O)2R9; —NH—S(═O)2R9, OC(═O)—C1-C6alkyl-S(═O)2R9, aryl, benzyl, heterocyclyl, aryloxy, benzyloxy, heterocyclyloxy, arylthio, benzylthio, heterocyclylthio; wherein the aryl, heterocyclyl, aryloxy, benzyloxy, heterocyclyloxy, arylthio, benzylthio and heterocyclylthio radicals are either unsubstituted or, depending on the possibilities of substitution on the ring, mono- to pentasubstituted by substituents selected from the group consisting of OH, halogen, CN, NO2, C1-C12alkyl, C1-C12haloalkyl, Si(C1-C8alkyl)3, C1-C12alkoxy-C1-C12alkoxy, C1-C12haloalkoxy, C3-C8cycloalkoxy, C2-C12alkenyloxy, C2-C12haloalkenyloxy, C2-C12haloalkenyl, C3-C12alkynyloxy, C2-C12haloalkynyl, C3-C12haloalkynyloxy, C3-C8cycloalkyl, C1-C12alkoxy, C1-C12haloalkoxy, C1-C12alkylthio, C1-C12haloalkylthio, C1-C6alkoxy-C1-C6alkyl, dimethylamino-C1-C6alkoxy, C2-C8alkenyl, C2-C8alkynyl, phenoxy, phenyl-C1-C6alkyl, methylenedioxy, —C(═O)R5, —O—C(═O)—R6, —NH—C(═O)R6, —N(R8)2, wherein the two R8 are independent of each other, C1-C6alkylsulfinyl, C3-C8cycloalkylsulfinyl, C1-C6haloalkylsulfinyl, C3-C8halocycloalkylsulfinyl, C1-C6alkylsulfonyl, C3-C8cycloalkylsulfonyl, C1-C6haloalkylsulfonyl and C3-C8halocycloalkylsulfonyl; R5 is H, OH, SH, —N(R8)2 wherein the two R8 are independent of each other, C1-C24alkyl, C2-C12alkenyl, C1-C8hydroxyalkyl, C1-C12haloalkyl, C1-C12alkoxy, C1-C,2haloalkoxy, C1-C6alkoxy-C1-C6alkyl, C1-C6alkoxy-C1-C6alkoxy, C1-C6alkoxy-C1-C6alkoxy-C1-C6alkyl, C1-C12alkylthio, C2-C8alkenyloxy, C3-C8alkynyloxy, Si(C1-C8alkyl)3, C1-C12alkoxy-C1-C12alkoxy, C1-C12haloalkoxy, C3-C8cycloalkoxy, C2-C12alkenyloxy, C2-C12haloalkenyloxy, C2-C12haloalkenyl, C3-C12alkynyloxy, C2-C12haloalkynyl, C3-C12haloalkynyloxy, NH—C1-C6alkyl-C(═O)R7, —N(C1-C6alkyl)-C1-C6alkyl-C(═O)—R7, —O—C1-C2alkyl-C(═O)R7, —C1-C6alkyl-S(═O)2R9, aryl, benzyl, heterocyclyl, aryloxy, benzyloxy, heterocyclyloxy; or aryl, benzyl, heterocyclyl, aryloxy, benzyloxy or heterocyclyloxy, which are independently of one another, depending on the substitution possibilities, mono- to trisubstituted in the ring by halogen, nitro, C1-C6alkyl, C1-C6alkoxy, C1-C6haloalkyl or C1-C6haloalkoxy; R6 is H, C1-C24alkyl, C1-C12haloalkyl, C1-C12hydroxyalkyl, C2-C8alkenyl, C2-C8alkynyl, C1-C6alkoxy-C1-C6alkyl, Si(C1-C8alkyl)3, C1-C12alkoxy-C1-C12alkoxy, C1-C12haloalkoxy, C3-C8Cycloalkoxy, C2-C12alkenyloxy, C2-C12haloalkenyloxy, C2-C12haloalkenyl, C3-C12alkynyloxy, C2-C12haloalkynyl, C3-C12haloalkynyloxy, (NR8)2, wherein the two R8 are independent of each other, —C1-C6alkyl-C(═O)R8, —C1-C6alkyl-S(═O)2R9, aryl, benzyl, heterocyclyl; or aryl, benzyl or heterocyclyl which, depending on the possibilities of substitution on the ring, are mono- to trisubstituted by substituents selected from the group consisting of OH, halogen, CN, NO2, C1-C12alkyl, C1-C12haloalkyl, C1-C12alkoxy, C1-C12haloalkoxy, C1-C12alkylthio, Si(C1-C8alkyl)3, C1-C12alkoxy-C1-C12alkoxy, C1-C12haloalkoxy, C3-C8cycloalkoxy, C2-C12alkenyloxy, C2-C12haloalkenyloxy, C2-C12haloalkenyl, C3-C12alkynyloxy, C2-C12haloalkynyl, C3-C12haloalkynyloxy and C1-C12haloalkylthio; R7 is H, OH, C1-C24alkyl that is optionally subsituted with OH, or —S(═O)2-C1-C6alkyl; C1-C12alkenyl, C2-C12alkynyl, C1-C12alkoxy, C1-C6 alkoxy-C1-C6alkyl, C1-C6alkoxy-C1-C6alkoxy, C2-C8alkenyloxy, aryl, aryloxy, benzyloxy, heterocyclyl, heterocyclyloxy or —N(R8)2, wherein the two R8 are independent of each other; R8 H, C1-C6alkyl, which is optionally substituted with one to five substituents selected from the group consisting of halogen, hydroxy, cyano C1-C6alkoxy, ═O, C2-C12alkenyl, C2-C12haloalkenyl, C2-C12haloalkynyl and C3-C12haloalkynyloxy; C3-C8-cycloalkyl, aryl, benzyl, heteroaryl; or aryl, benzyl or heteroaryl, which, depending on the possibilities of substitution on the ring, are mono- to trisubstituted by substituents selected from the group consisting of OH, halogen, CN, NO2, C1-C12alkyl, C1-C12haloalkyl, C1-C12alkoxy, C1-C12haloalkoxy, Si(C1-C8alkyl)3, C1-C12alkoxy-C1-C12alkoxy, C1-C12haloalkoxy, C3-C8cycloalkoxy, C2-C12alkenyloxy, C2-C12haloalkenyloxy, C2-C12haloalkenyl, C3-C12alkynyloxy, C2-C12haloalkynyl, C3-C12haloalkynyloxy, C1-C12alkylthio and C1-C12haloalkylthio; R9 is H, C1-C6alkyl, which is optionally substituted with one to five substituents selected from the group consisting of halogen, C1-C6alkoxy, OH, ═O, C2-C12alkenyl, C2-C12haloalkenyl, C2-C12haloalkynyl, C2-C12haloalkynyl and cyano; aryl, benzyl, heteroaryl; or aryl, benzyl or heteroaryl, which, depending on the possibilities of substitution on the ring, are mono- to trisubstituted by substituents selected from the group consisting of OH, halogen, CN, NO2, C1-C12alkyl, C1-C12haloalkyl, Si(C1-C8alkyl)3, C1-C12alkoxy, C1-C12alkoxy-C1-C12alkoxy, C1-C12haloalkoxy, C3-C8cycloalkoxy, C2-C12alkenyloxy, C2-C12haloalkenyloxy, C2-C12haloalkenyl, C3-C12alkynyloxy, C2-C12haloalkynyl, C3-C12haloalkynyloxy, C1-C12alkylthio and C1-C12haloalkylthio; or, if appropriate, an E/Z isomer, E/Z isomer mixture and/or tautomer thereof; a process for preparing these compounds, their isomers and tautomers and the use of these compounds, their isomers and tautomers; pesticidal compositions whose active compound is selected from these compounds and their tautomers; intermediates for the preparation of the said compounds of the formula (I), methods for the preparation of the compounds of the formula (I), and a method for controlling pests using these compositions. Hereinbefore and hereinafter, the configuration at the ε-position (4′- or 4″-position) of the compounds of the formulae (I) and (III) may be (S) as well as (R). The literature proposes certain macrolide compounds for controlling pests. However, the biological properties of these known compounds are not entirely satisfactory, and, as a consequence, there is still a need for providing further compounds having pesticidal properties, in particular for the control of insects and representatives of the order Acarina. According to the invention, this object is achieved by providing the present compounds of the formulae (I), (II) and (III). The compounds claimed according to the invention are derivatives of Avermectin. Avermectins are known to the person skilled in the art. They are a group of structurally closely related pesticidally active compounds which are obtained by fermenting a strain of the microorganism Streptomyces avermitilis. Derivatives of Avermectins can be obtained by conventional chemical syntheses. The Avermectins which can be obtained from Streptomyces avermitilis are referred to as A1a, A1b, A2a, A2b, B1a, B1b, B2a and B2b. The compounds referred to as “A” and “B” have a methoxy radical and an OH group, respectively, in the 5-position. The “a” series and the “b” series are compounds in which the substituent R1 (in position 25) is a sec-butyl radical and an isopropyl radical, respectively. The number 1 in the name of the compounds means that carbon atoms 22 and 23 are linked by double bonds; the number 2 means that they are linked by a single bond and that the C atom 23 carries an OH group. The above nomenclature is adhered to in the description of the present invention to denote the specific structure type in the not naturally occurring Avermectin derivatives according to the invention which corresponds to the naturally occurring Avermectin. What is for instance claimed according to the invention are derivatives of compounds of the B1 series, in particular mixtures of derivatives of Avermectin B1, especially B1a and B1b, along with derivatives having a single bond between carbon atoms 22 and 23, and derivatives having other substituents in the 25-position, as well as the corresponding monosaccharides. Some of the compounds of the formula (I) can be present as tautomers. Accordingly, hereinabove and hereinbelow, the compounds of the formula (I) are, if appropriate, also to be understood as including the corresponding tautomers, even if the latter are not specifically mentioned in each case. The compounds of formula (I) and, where applicable, their tautomers can form salts, for example acid addition salts. These acid addition salts are formed, for example, with strong inorganic acids, such as mineral acids, for example sulfuric acid, a phosphoric acid or a hydrohalic acid, with strong organic carboxylic acids, such as unsubstituted or substituted, for example halo-substituted, C1-C4alkanecarboxylic acids, for example acetic acid, unsaturated or saturated dicarboxylic acids, for example oxalic acid, malonic acid, maleic acid, fumaric acid or phthalic acid, hydroxycarboxylic acids, for example ascorbic acid, lactic acid, malic acid, tartaric acid or citric acid, or benzoic acid, or with organic sulfonic acids, such as unsubstituted or substituted, for example halo-substituted, C1-C4alkane- or aryl-sulfonic acids, for example methane- or p-toluene-sulfonic acid. Compounds of formula (I) that have at least one acidic group can furthermore form salts with bases. Suitable salts with bases are, for example, metal salts, such as alkali metal salts or alkaline earth metal salts, for example sodium, potassium or magnesium salts, or salts with ammonia or with an organic amine, such as morpholine, piperidine, pyrrolidine, a mono-, di- or tri-lower alkylamine, for example ethylamine, diethylamine, triethylamine or dimethylpropylamine, or a mono-, di- or trihydroxy-lower alkylamine, for example mono-, di- or tri-ethanolamine. Corresponding internal salts may also be formed where appropriate. The free form is preferred. Among the salts of the compounds of formula (I), the agrochemically advantageous salts are preferred. Hereinbefore and hereinafter, any reference to the free compounds of formula (I) or their salts is to be understood as including, where appropriate, also the corresponding salts or the free compounds of formula (I), respectively. The same applies to tautomers of compounds of formula (I) and salts thereof. Unless defined otherwise, the general terms used hereinabove and hereinbelow have the meanings given below. Unless defined otherwise, carbon-containing groups and compounds each contain from 1 up to and including 6, preferably from 1 up to and including 4, especially 1 or 2, carbon atoms. Halogen—as a group per se and also as a structural element of other groups and compounds, such as haloalkyl, haloalkoxy and haloalkylthio—is fluorine, chlorine, bromine or iodine, in particular fluorine, chlorine or bromine, especially fluorine or chlorine. Alkyl—as a group per se and also as a structural element of other groups and compounds, such as haloalkyl, alkoxy and alkylthio—is, in each case taking into account the number of carbon atoms contained in each case in the group or compound in question, either straight-chain, i.e. methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl or octyl, or branched, for example isopropyl, isobutyl, sec-butyl, tert-butyl, isopentyl, neopentyl or isohexyl. Cycloalkyl—as a group per se and also as a structural element of other groups and compounds, such as, for example, of halocycloalkyl, cycloalkoxy and cycloalkylthio is, in each case taking into account the number of carbon atoms contained in each case in the group or compound in question, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, cycloheptyl or cyclooctyl. Alkenyl—as a group per se and also as a structural element of other groups and compounds—is, taking into account the number of carbon atoms and conjugated or isolated double bonds contained in the group, either straight-chain, for example vinyl, allyl, 2-butenyl, 3-pentenyl, 1-hexenyl, 1-heptenyl, 1,3-hexadienyl or 1,3-octadienyl, or branched, for example isopropenyl, isobutenyl, isoprenyl, tert-pentenyl, isohexenyl, isoheptenyl or isooctenyl. Preference is given to alkenyl groups having 3 to 12, in particular 3 to 6, especially 3 or 4, carbon atoms. Alkynyl—as a group per se and also as a structural element of other groups and compounds—is, in each case taking into account the number of carbon atoms and conjugated or isolated double bonds contained in the group or compound in question, either straight-chain, for example ethynyl, propargyl, 2-butynyl, 3-pentynyl, 1-hexynyl, 1-heptynyl, 3-hexen-1-ynyl or 1,5-heptadien-3-ynyl, or branched, for example 3-methylbut-1-ynyl, 4-ethylpent-1-ynyl, 4-methylhex-2-ynyl or 2-methylhept-3-ynyl. Preference is given to the group —CH2—C2-C11alkynyl, in particular —CH2—C2-C5alkynyl, especially —CH2—C2-C3alkynyl. Alkylene and alkenylene are straight-chain or branched bridge members; they are in particular —CH2—CH2—CH2—, —CH2—CH2—CH2—CH2—, —CH2—CH2—CH2—CH2—CH2—, —CH2(CH3)CH2—CH2—, —CH2C(CH3)2—CH2—, —CH2—CH═CH—, —CH2—CH═CH—CH2 or —CH2—CH═CH—CH2—CH2—. Halogen-substituted carbon-containing groups and compounds, such as, for example, halogen-substituted alkyl, alkenyl, alkynyl, cycloalkyl, alkoxy or alkylthio, can be partially halogenated or perhalogenated, where in the case of polyhalogenation the halogen substituents can be identical or different. Examples of haloalkyl—as a group per se and also as a structural element of other groups and compounds, such as haloalkoxy or haloalkylthio—are methyl which is mono- to trisubstituted by fluorine, chlorine and/or bromine, such as CHF2 or CF3; ethyl which is mono- to pentasubstituted by fluorine, chlorine and/or bromine, such as CH2CF3, CF2CF3, CF2CCl3, CF2CHCl2, CF2CHF2, CF2CFCl2, CF2CHBr2, CF2CHClF, CF2CHBrF or CClFCHClF; propyl or isopropyl which is mono- to heptasubstituted by fluorine, chlorine and/or bromine, such as CH2CHBrCH2Br, CF2CHFCF3, CH2CF2CF3, CF(CF3)2 or CH(CF3)2; butyl or one of its isomers, mono- to nonasubstituted by fluorine, chlorine and/or bromine, such as CF(CF3)CHFCF3 or CH2(CF2)2CF3; pentyl or one of its isomers, mono- to undecasubstituted by fluorine, chlorine and/or bromine, such as CF(CF3)(CHF2)CF3 or CH2(CF2)3CF3; and hexyl or one of its isomers, mono- to tridecasubstituted by fluorine, chlorine and/or bromine, such as (CH2)4CHBrCH2Br, CF2(CHF)4CF3, CH2(CF2)4CF3 or C(CF3)2(CHF)2CF3. Aryl is in particular phenyl, naphthyl, anthracenyl, phenanthrenyl, perylenyl or fluorenyl, preferably phenyl. Heterocyclyl is understood as being a three- to seven-membered monocyclic ring, which may be saturated or unsaturated, and that contains from one to three hetero atoms selected from the group consisting of N, O and S, especially N and S; or a bicyclic ring-system having from 8 to 14 ring atoms, which may be saturated or unsaturated, and that may contain either in only one ring or in both rings independently of one another, one or two hetero atoms selected from N, O and S. Heterocyclyl is in particular piperidinyl, piperazinyl, oxiranyl, morpholinyl, thiomorpholinyl, pyridyl, N-oxidopyridinio, pyrimidyl, pyrazinyl, s-triazinyl, 1,2,4-triazinyl, thienyl, furanyl, dihydrofuranyl, tetrahydrofuranyl, pyranyl, tetrahydropyranyl, pyrrolyl, pyrrolinyl, pyrrolidinyl, pyrazolyl, imidazolyl, imidazolinyl, thiazolyl, isothiazolyl, triazolyl, oxazolyl, thiadiazolyl, thiazolinyl, thiazolidinyl, oxadiazolyl, phthalimidoyl, benzothienyl, quinolinyl, quinoxalinyl, benzofuranyl, benzimidazolyl, benzpyrrolyl, benzthiazolyl, indolinyl, isoindolinyl, cumarinyl, indazolyl, benzothiophenyl, benzofuranyl, pteridinyl or purinyl, which are preferably attached via a C atom; thienyl, benzofuranyl, benzothiazolyl, tetrahydropyranyl or indolyl is preferred; in particular pyridyl or thiazolyl. The said heterocyclyl radicals may preferrably be unsubstituted or—depending on the substitution possibilities on the ring system—substituted by 1 to 3 substituents selected from the group consisting of halogen, ═O, —OH, ═S, SH, nitro, C1-C6alkyl, C1-C6hydroxyalkyl, C1-C6alkoxy, C1-C6haloalkyl, C1-C6haloalkoxy, phenyl, benzyl, —C(═O)—R6 and —CH2—C(═O)—R6. In the context of the present invention, preference is given to (2) compounds according to group (1) of the formula (I) in which R1 is isopropyl or sec-butyl, preferably to those in which a mixture of the isopropyl and the sec-butyl derivative is present; (3) compounds according to group (1) of the formula (I) in which R1 is cyclohexyl; (4) compounds according to group (1) of the formula (1) in which R1 is 1-methyl-butyl; (5) compounds according to one of the groups (1) to (4) of the formula (I) in which the configuration at the ε-position is (R); (6) compounds according to one of the groups (1) to (4) of the formula (I) in which the configuration at the ε-position is (S); (7) compounds according to one of the groups (1) to (6) of the formula (I) in which n is 1; (8) compounds according to one of the groups (1) to (6) of the formula (I) in which n is 0; (9) compounds according to one of the groups (1) to (8) of the formula (I) in which X—Y is —CH═CH—; (10) compounds according to one of the groups (1) to (8) of the formula (I) in which X—Y is —CH2—CH2—; (11) compounds according to one of the groups (1) to (10) of the formula (I) in which U is —N(R2)—O(R3) (12) compounds according to one of the groups (1) to (10) of the formula (I) in which U is —N+(O−)═C(RZ)(RE) (13) compounds according to group (11) of the formula (I) in which R3 is -Q, —C(═O)-Z-Q or —CN and R2 is independently taken from -Q; (14) compounds according to group (11) of the formula (I) in which R3 is -Q, —C(═O)-Z-Q or —CN and R2 is independently taken from —C(═O)-Z-Q; (15) compounds according to group (11) of the formula (I) in which R3 is -Q, —C(═O)-Z-Q or —CN and R2 is —CN; (16) compounds according to group (11) of the formula (I) in which R2 is Q, —C(═O)-Z-Q or —CN and R3 is independently taken from -Q; (17) compounds according to group (11) of the formula (I) in which R2 is -Q, —C(═O)-Z-Q or —CN and R3 is independently taken from —C(═O)-Z-Q; (18) compounds according to group (11) of the formula (I) in which R2 is -Q, —C(═O)-Z-Q or —CN and R3 is —CN; (19) compounds according to one of the groups (13) to (18) of the formula (I) in which Z is a bond; (20) compounds according to one of the groups (13) to (18) of the formula (I) in which Z is O; (21) compounds according to one of the groups (13) to (18) of the formula (I) in which Z is —NR4—; (22) compounds according to group (11) of the formula (I) in which R2 and R3together are a three membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (23) compounds according to group (11) of the formula (I) in which R2 and R3together are a four membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (24) compounds according to group (11) of the formula (I) in which R2 and R3 together are a five membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (25) compounds according to group (11) of the formula (I) in which R2 and R3together are a six membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (26) compounds according to group (11) of the formula (I) in which R2 and R3together are a seven membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (27) compounds according to group (11) of the formula (I) in which R2 and R3together are a three membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted; (28) compounds according to group (11) of the formula (I) in which R2 and R3 together are a four membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted; (29) compounds according to group (11) of the formula (I) in which R2 and R3 together are a five membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted; (30) compounds according to group (11) of the formula (I) in which R2 and R3 together are a six membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted; (31) compounds according to group (11) of the formula (I) in which R2 and R3together are a seven membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted; (32) compounds according to group (12) of the formula (I) in which RE is -Q, —C(═O)-Z-Q or —CN and RZ is independently taken from -Q; (33) compounds according to group (12) of the formula (I) in which RE is -Q. —C(═O)-Z-Q or —CN and RZ is independently taken from —C(═O)-Z-Q; (34) compounds according to group (12) of the formula (I) in which RE is -Q, —C(═O)-Z-Q or —ON and RZ is —ON; (35) compounds according to group (12) of the formula (I) in which RZ is -Q, —C(═O)-Z-Q or —CN and RE is independently taken from -Q; (36) compounds according to group (12) of the formula (I) in which RZ is Q, —C(═O)-Z-Q or —ON and RE is independently taken from —C(═O)-Z-Q; (37) compounds according to group (12) of the formula (I) in which RZ is -Q, —C(═O)-Z-Q or —ON and RE is —CN; (38) compounds according to one of the groups (32) to (37) of the formula (I) in which Z is a bond; (39) compounds according to one of the groups (32) to (37) of the formula (I) in which Z is O; (40) compounds according to one of the groups (32) to (37) of the formula (I) in which Z is —NR4—; (41) compounds according to group (12) of the formula (I) in which RZ and RE together are a three membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (42) compounds according to group (12) of the formula (I) in which RZ and RE together are a four membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (43) compounds according to group (12) of the formula (I) in which RZ and RE together are a five membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (44) compounds according to group (12) of the formula (I) in which RZ and RE together are a six membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (45) compounds according to group (12) of the formula (I) in which RZ and RE together are a seven membered alkylene bridge, which is unsubstituted or mono- to tri-substituted; (46) compounds according to group (12) of the formula (I) in which RZ and RE together are a three membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted; (47) compounds according to group (12) of the formula (I) in which RZ and RE together are a four membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted; (48) compounds according to group (12) of the formula (I) in which RZ and RE together are a five membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted; (49) compounds according to group (12) of the formula (I) in which RZ and RE together are a six membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted; (50) compounds according to group (12) of the formula (I) in which RZ and RE together are a seven membered alkenylene bridge, which is unsubstituted or mono- to tri-substituted. Special preference is given within the scope of the invention to the compounds of formula (I) listed in Tables A1 to A8 and in Tables 1 to 48 and, where applicable, their tautomers, their mixtures of tautomers, their E/Z isomers and mixtures of E/Z isomers. The invention also provides a process for preparing the compounds of the formula (I) and, if appropriate, tautomers thereof, wherein (A) for the preparation of a compound of the formula (I) as defined under (1), wherein U is —NHOR3 and R3 has the same meanings as given under (1) for formula (I), a compound of the formula in which G is H or a protecting group, n, X—Y, R1 and R3 have the same meanings as given above under (1) for formula (I), is treated with a reducing agent; or (B) for the preparation of a compound of the formula wherein G is H or a protecting group, n, X—Y, R1, RE and RZ have the same meanings as given above under (1) for formula (I), a compound of the formula in which G is H or a protecting group, R2 and R3 are H, and n, X—Y and R1 have the same meanings as given above under (1) for formula (I), is reacted with a compound of the formula RE—C(═O)—RZ, in which RE and RZ have the same meanings as given above under (1) for formula (I); or (C) for the preparation of a compound of the formula (Ia) as defined above under (B), a compound of the formula in which n, X—Y, R1, RE and RZ have the same meanings as given above under (1) for formula (I), is treated with an oxidating agent; or (D) for the to preparation of a compound of the formula (Ib) as defined above under (B), wherein R2 and R3 are H, a compound of the formula (Ia) as defined above under (B), is reacted with a compound of the formula Q1-O—NH2, in which Q1 is H, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C12cycloalkyl, C5-C12cycloalkenyl, aryl or heterocyclyl, which are unsubstituted or mono- to pentasubstituted, and wherein the substituents of the alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl and heterocyclyl radicals mentioned have the same meaning as given above under (1) for formula (I); or (E) for the preparation of a compound of the formula in which G is H or a protecting group, n, X—Y, R1, RE and RZ have the same meanings as given above under (1) for formula (I), a compound of the formula (Ia) as defined above under (B) is reacted with a reducing agent; or (F) for the preparation of a compound of the formula in which G is H or a protecting group, n, X—Y, R1, RE and RZ have the same meanings as given above under (1) for formula (I), and Q2 is H, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C12cycloalkyl, C5-C12-cycloalkenyl, aryl or heterocyclyl, which are unsubstituted or mono- to pentasubstituted, and wherein the substituents of the alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl and heterocyclyl radicals mentioned have the same meaning as given above under (1) for formula (I); a compound of the formula (Ia) as defined above under (B) is reacted with a compound Q2-M or a compound, wherein Q2-M-X1, both in which Q2 has the same meaning as given above and M is lithium, magnesium or zinc, and X1 is chloride, bromide, iodide or trifluoro-methanesulfonate; or (G) for the preparation of a compound of the formula in which G is H or a protecting group, n, X—Y, R1, RE and RZ have the same meanings as given above under (1) for formula (I), and in which Q3 and Q4 are, independently from each other, H, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C12-cycloalkyl, C5-C12cycloalkenyl, aryl or heterocyclyl, which are unsubstituted or mono- to pentasubstituted, and wherein the substituents of the alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl and heterocyclyl radicals mentioned have the same meaning as given above under (1) for formula (I); a compound of the formula (Ia) as defined above under (B) is reacted with a compound Q3-C≡C-Q4, in which Q3 and Q4 have the same meaning as given above; or (H) for the preparation of a compound of the formula in which G is H or a protecting group, n, X—Y, R1, RE and RZ have the same meanings as given above under (1) for formula (I), and in which Q5, Q6, Q7 and Q8 are, independently from each other, H, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C12cycloalkyl, C5-C12cycloalkenyl, aryl or heterocyclyl, which are unsubstituted or mono- to pentasubstituted, and wherein the substituents of the alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl and heterocyclyl radicals mentioned have the same meaning as given above under (1) for formula (I); a compound of the formula (Ia) as defined above under (B) is reacted with a compound Q5Q6C═CQ7Q8, in which Q5, Q6, Q7 and Q8 have the same meaning as given above under (H) for formula (If); or (J) for the preparation of a compound of the formula (Ib) a defined above under (B), in which R2 and R3 have the same meanings as given above under (1) for formula (I), a compound of the formula (Ib) as defined above under (B), wherein R2 is H and R3 is as defined under (1) for formula (I), is reacted with a compound Q-X2, with a compound Q-C(═O)—Cl, with a compond Q-O—C(═O)—Cl, with a compound Q-N═C═O or with a compound in which Q has the same meaning as given above under (1) for formula (I) and X2 is chloride, bromide, iodide, alkylsulfonate, haloalkylsulfonate or arylsulfonate; or (K) for the preparation of a compound of the formula (Ib) as defined above under (B), and wherein R2 and R3 have the same meanings as given above under (1) for formula (I), a compound of the formula (Ib) as defined above under (B), wherein R2 has the same meanings as given above under (1) for formula (I) and R3 is H, is reacted with a compound Q-X2, wherein X2 is chloride, bromide, iodide, alkylsulfonate, haloalkylsulfonate or arylsulfonate, or with a compound Q-C(═O)—Cl, with a compond Q-O—C(═O)—Cl or with a compound Q-N═C═O, in which Q has the same meaning as given above under (1) for formula (I); or (L) for the preparation of a compound of the formula (I) in which G is H or a protecting group, n, X—Y, R1 and R3 have the same meanings as given above under (1) for formula (I), X3 is —CN or —CO-Q12 or —CO—O-Q12, and Q9, Q10, Q11 and Q12 are, independently from each other, H, C1-C12alkyl, C2-C12alkenyl, C2-C12alkynyl, C3-C12cycloalkyl, C5-C12cycloalkenyl, aryl or heterocyclyl, which are unsubstituted or mono- to pentasubstituted, and wherein the substituents of the alkyl, alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl and heterocyclyl radicals mentioned have the same meaning as given above under (1) for formula (I); a compound of the formula (Ib), as defined above under (B), in which R2 is H and and R3 has the same meanings as given above under (1) for formula (I), is reacted with a compound Q10Q11C═CQ9X3, in which Q9, Q10, Q11 and X3 have the same meaning as given above under (L) for formula (I); and in each case of variants (A) to (L), if required for the synthesis of a compound of the formula (I), wherein the substituent in the 5-position is OH, the protecting group is removed. The compounds of formulae (II) and of formula (III) are new, and are also an aspect of the invention. They are valuable intermediates for the synthesis of compounds of formula (I), and can be prepared by methods known per se. Surprisingly, they are also valuable pesticides. The use of the compounds of formula (II) and of formula (III), and of the compounds of the formula (I) having in the 5-position a protecting group, for the synthesis of compounds of formula (I), a method for controlling pests with the said compounds of the formulae (II) and (III), and pesticidal compositions containing them are also subjects of this invention. The preferences for the substituents are the same as defined for the compound of the formula (I) in (2) to (50). The compounds of the formula (I), (II) and (III) wherein the group G in the 5-position is H are preferred. The comments made above in connection with tautomers of compounds of formula (I) apply analogously to the starting materials and intermediates mentioned hereinabove and hereinbelow in respect of their tautomers. Compounds of formula (I) bearing a functional group in its free or protected form can be used as starting materials for the preparation of further compounds of formula (I). For such manipulations methods known to the person skilled in the art can be applied. For example a compound of formula (I) wherein Q is CH2CH2OC(═O)CH3 can be converted to a compound of formula (I) wherein Q is CH2CH2OH. Further standard reactions can deliver compounds of formula (I) wherein Q is —CH2CH2OCH2O-Alkyl or —CH2CH2N3. A compound of formula (I) wherein Q is —CH2CH2N3 can be converted to a compound of formula (I) wherein Q is —CH2CH2NH2. Treatment of such a compound of formula (I) for instance with Hal-C(═O)R5, gives compounds of formula (I) wherein Q is —CH2CH2NHCOR5. The reactions described hereinabove and hereinbelow are carried out in a manner known per se, for example in the absence or, customarily, in the presence of a suitable solvent or diluent or of a mixture thereof, the reactions being carried out, as required, with cooling, at room temperature or with heating, for example in a temperature range of approximately from −80° C. to the boiling temperature of the reaction medium, preferably from approximately 0° C. to approximately +150° C., and, if necessary, in a closed vessel, under pressure, under an inert gas atmosphere and/or under anhydrous conditions. Especially advantageous reaction conditions can be found in the Examples. The reaction time is not critical; a reaction time of from about 0.1 to about 24 hours, especially from about 0.5 to about 10 hours, is preferred. The product is isolated by customary methods, for example by means of filtration, crystallization, distillation or chromatography, or any suitable combination of such methods. The starting materials mentioned hereinabove and hereinbelow that are used for the preparation of the compounds of formula (I) and, where applicable, their tautomers can be prepared by methods known per se, e.g. as indicated below. Protecting groups G in the compounds of formulae (I), (II) and (III) include: alkyl ether radicals, such as methoxymethyl, methylthiomethyl, tert-butylthiomethyl, benzyloxymethyl, p-methoxybenzyl, 2-methoxyethoxymethyl, 2,2,2-trichloroethoxymethyl, 2-(trimethylsilyl)ethoxymethyl, tetrahydropyranyl, tetrahydrofuranyl, 1-ethoxyethyl, 1-(2-chloroethoxy)ethyl, 1-methyl-1-methoxyethyl, 1-methyl-1-benzyloxyethyl, trichloroethyl, 2-trimethylsilylethyl, tert-butyl, allyl, p-methoxyphenyl, 2,4-dinitrophenyl, benzyl, p-methoxybenzyl, o-nitrobenzyl, p-nitrobenzyl, triphenylmethyl; trialkylsilyl radicals, such as trimethylsilyl, triethylsilyl, dimethyl-tert-butylsilyl, dimethyl-isopropylsilyl, dimethyl-1,1,2-trimethylpropylsilyl, diethyl-isopropylsilyl, dimethyl-tert-hexylsilyl, but also phenyl-tert-alkylsilyl groups, such as diphenyl-tert-butylsilyl; esters, such as formates, acetates, chloroacetates, dichloroacetates, trichloroacetates, trifluoroacetates, methoxyacetates, phenoxyacetates, pivaloates, benzoates; alkyl carbonates, such as methyl-, 9-fluorenylmethyl-, ethyl-, 2,2,2-trichloroethyl-, 2-(trimethylsilyl)ethyl-, vinyl-, allyl-, benzyl-, p-methoxybenzyl-, o-nitrobenzyl-, p-nitrobenzyl-, but also p-nitrophenyl-carbonate. Preference is given to trialkylsilyl radicals, such as trimethylsilyl, triethylsilyl, dimethyl-tert-butylsilyl, diphenyl-tert-butylsilyl, esters, such as methoxyacetates and phenoxyacetates, and carbonates, such as 9-fluorenylmethylcarbonates and allylcarbonates. Dimethyl-tert-butylsilyl ether is especially preferred. There are suitable for the removal of the protecting group Lewis acids, such as hydrochloric acid, methanesulfonic acid, BF3*OEt2, HF in pyridine, Zn(BF4)2*H2O, p-toluenesulfonic acid, AlCl3, HgCl2; ammonium fluoride, such as tetrabutylammonium fluoride; bases, such as ammonia, trialkylamine or heterocyclic bases; hydrogenolysis with a catalyst, such as palladium-on-carbon; reducing agents, such as sodium borohydride or tributyltin hydride with a catalyst, such as Pd(PPh3)4, or also zinc with acetic acid. Preference is given to acids, such as methanesulfonic acid or HF in pyridine; sodium borohydride with Pd(0); bases, such as ammonia, triethylamine or pyridine; especially acids, such as HF in pyridine or methanesulfonic acid. Process Variant (A): Examples of solvents and diluents include: aromatic, aliphatic and alicyclic hydro-carbons and halogenated hydrocarbons, such as benzene, toluene, xylene, mesitylene, tetraline, chlorobenzene, dichlorobenzene, bromobenzene, petroleum ether, hexane, cyclohexane, dichloromethane, trichloromethane, tetrachloromethane, dichloroethane, trichloroethene or tetrachloroethene; ethers, such as diethyl ether, dipropyl ether, diisopropyl ether, dibutyl ether, tert-butyl methyl ether, ethylene glycol monomethyl ether, ethylene glycol monoethyl ether, ethylene glycol dimethyl ether, dimethoxydiethyl ether, tetrahydrofuran or dioxane; alcohols, such as methanol, ethanol, propanol, isopropanol, butanol, ethylene glycol or glycerol; carboxylic acids, such as acetic acid, pivalic acid or formic acid; ketones, such as acetone, methyl ethyl ketone or methyl isobutyl ketone; carboxylic acid esters, such as methyl acetate, ethyl acetate, or esters of benzoic acid; amides, such as N,N-dimethylformamide, N, N-diethylformamide, N, N-dimethylacetamide, N-methyl-pyrrolidone or hexamethylphosphoric acid triamide; nitriles, such as acetonitrile or propionitrile; and sulfoxides, such as dimethyl sulfoxide; and also water; or mixtures of the mentioned solvents; especially suitable are ethers, alcohols, water, carboxylic acids, or mixtures thereof, more especially tetrahydrofuran, pivalic acid or water. The reactions are advantageously carried out in a temperature range of from about room temperature to the boiling point of the solvent used; preference being given to reaction at 10 to 30° C. Examples of reducing agents are known to a person skilled in the art, they include hydrides; especially suitable are borohydrides, for example sodium borohydride or sodium cyanoborohydride. In a preferred embodiment of Variant (A) the reaction is carried out with sodium cyanoborohydride at room temperature, in tetrahydrofuran in the presence of pivalic acid and water. Especially preferred conditions for this Process variant are described in Examples A1.1, A1.2, A5.1 and A6.1. Process Variant (B): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are esters, water or mixtures thereof, or the use of no solvent. The reactions are advantageously carried out in a temperature range of from about room temperature to the boiling point of the solvent used; preference being given to reaction at 10 to 30° C. Examples of a compound RE—C(═O)—RZ include ketones or aldehydes, for example formaldehyde, acetaldehyde, benzaldehyde or acetone. In a preferred embodiment of Variant (B) the reaction is carried out with the compound RE—C(═O)—RZ as the solvent. In another preferred embodiment of Variant (B) the reaction is carried out with the compound RE—C(═O)—RZ in a mixture of ethyl acetate and water. Especially preferred conditions for this Process variant are described, for example, in Examples A7.1 and A7.2. Process Variant (C): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are halogenated hydrocarbons, for example dichloromethane or trichloromethane. The reactions are advantageously carried out in a temperature range of from 0° C. to the boiling point of the solvent used, preferably from 0° C. to room temperature. Examples of oxidating agents are known to a person skilled in the art, they include, for example, inorganic salts, for example sodium periodate or potassium permanganate; oxides, for example selenium dioxide or mercury oxide; peroxides, for example hyrogenperoxide or dimethyldioxirane; or peracids; especially suitable are peracids, for example 3-chloroperbenzoic acid or peracetic acid. Especially preferred conditions for this Process variant are described, for example, in Example A8.1. Process Variant (D): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are alcohols, for example ethanol, methanol or iso-propanol. Process Variant (D): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are alcohols, for example ethanol, methanol or iso-propanol. The reactions are advantageously carried out in a temperature range of approximately from room temperature to the boiling point of the solvent used. Examples of a compound Q1-O—NH2 include N-unsubstituted hydroxylamines, for example O-methylhydroxylamine, O-phenylhydroxylamine or hydroxylamine. In a preferred embodiment of Variant (D) the reaction is carried out with hydroxylamine hydrochloride, in the presence of sodium bicarbonate, at 60° C. in methanol as the solvent. Especially preferred conditions for this Process variant are described, for example, in Example A4.1. Process Variant (E): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are ethers, alcohols, water, carboxylic acids, or mixtures thereof, more especially tetrahydrofuran, acetic acid or water. The reactions are advantageously carried out in a temperature range of from about room temperature to the boiling point of the solvent used; preference being given to reaction at 10 to 30° C. Examples of reducing agents are known to a person skilled in the art, they include hydrides; especially suitable are borohydrides, for example sodium borohydride or sodium cyanoborohydride. In a preferred embodiment of Variant (E) the reaction is carried out with sodium cyanoborohydride at room temperature, in tetrahydrofuran as the solvent. Especially preferred conditions for this Process variant are described, for example, in Example A2.1. Process Variant (F): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are ethers, for example diethyl ether or tetrahydrofuran. The reactions are advantageously carried out in a temperature range of from 0° C. to the boiling point of the solvent used, preferably at room temperature. Especially preferred conditions for this Process variant are described, for example, in Examples A2.2, A2.3 and A2.6. Process Variant (G): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are ethers, for example diethyl ether or tetrahydrofuran, or aromatic hydrocarbons such as benzene, toluene or xylene, or the use of no solvent. The reactions are advantageously carried out in a temperature range of from 0° C. to the boiling point of the solvent used, preferably from 0° C. to 80° C. In a preferred embodiment of Variant (G) the reaction is carried out at 0° C., in tetrahydrofuran as the solvent. Especially preferred conditions for this Process variant are described, for example, in Example A3.2. Process Variant (H): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are ethers, for example diethyl ether or tetrahydrofuran, or aromatic hydrocarbons such as benzene, toluene or xylene, or the use of no solvent. The reactions are advantageously carried out in a temperature range of from 0° C. to the boiling point of the solvent used, preferably from 0° C. to 80° C. In a preferred embodiment of Variant (H) the reaction is carried out at 80° C., in toluene as the solvent. Especially preferred conditions for this Process variant are described, for example, in Example A3.1. Process Variant (J): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are hydrocarbons, aromatic hydrocarbons, halogenated hydrocarbons, esters or ethers, for example hexane, toluene, dichloromethane, ethyl acetate or tetrahydrofuran; or water; or mixtures thereof. The reactions are advantageously carried out in a temperature range of from 0° C. to the boiling point of the solvent used, preferably from 0° C. to room temperature; in the presence of a base, for example an inorganic base, such as sodium hydroxide, potassium hydroxide, sodium carbonate or sodium bicarbonate, or an organic base, such as pyridine, triethylamine or N-ethyl-N,N-diisopropylamine; or without the presence of a base. In a preferred embodiment of Variant (J) the reaction is carried out in the presence of bicarbonate at room temperature, in a mixture of ethyl acetate and water as the solvent. In another preferred embodiment of Variant (J) the reaction is carried out without a base at room temperature, in ethyl acetate as the solvent. Especially preferred conditions for this Process variant are described, for example, in Examples A1.3, A1.4 and A2.4. Process Variant (K): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are hydrocarbons, aromatic hydrocarbons, halogenated hydrocarbons, esters or ethers, for example hexane, toluene, dichloromethane, ethyl acetate or tetrahydrofuran; or water; or mixtures thereof. The reactions are advantageously carried out in a temperature range of from 0° C. to the boiling point of the solvent used, preferably from 0° C. to room temperature; in the presence of a base, for example an inorganic base, such as sodium hydroxide, potassium hydroxide, sodium carbonate or sodium bicarbonate, or an organic base, such as pyridine, triethylamine or N-ethyl-N,N-diisopropylamine; or without the presence of a base. In a preferred embodiment of Variant (K) the reaction is carried out in the presence of bicarbonate at room temperature, in a mixture of ethyl acetate and water as the solvent. In another preferred embodiment of Variant (K) the reaction is carried out without a base at room temperature, in ethyl acetate as the solvent. Especially preferred conditions for this Process variant are described, for example, in Examples A2.7 and A2.8. Process Variant (L): Examples of solvents and diluents include those listed above under Process variant (A); especially suitable are ethers, for example diethyl ether or tetrahydrofuran, or aromatic hydrocarbons such as benzene, toluene or xylene, or the use of no solvent. The reactions are advantageously carried out in a temperature range of from 0° C. to the boiling point of the solvent used, preferably from 0° C. to 80° C. In a preferred embodiment of Variant (L) the reaction is carried out at room temperature, without the use of a solvent. Especially preferred conditions for this Process variant are described, for example, in Example A2.5. The compounds of formula (I) may be in the form of one of the possible isomers or in the form of a mixture thereof, in the form of pure isomers or in the form of an isomeric mixture, i.e. in the form of a diastereomeric mixture; the invention relates both to the pure isomers and to the diastereomeric mixtures and is to be interpreted accordingly hereinabove and hereinbelow, even if stereochemical details are not mentioned specifically in every case. The diastereomeric mixtures can be resolved into the pure isomers by known methods, for example by recrystallisation from a solvent, by chromatography, for example high pressure liquid chromatography (HPLC) on acetylcellulose, with the aid of suitable micro-organisms, by cleavage with specific, immobilised enzymes, or via the formation of inclusion compounds, for example using crown ethers, only one isomer being complexed. Apart from by separation of corresponding mixtures of isomers, pure diastereoisomers can be obtained according to the invention also by generally known methods of stereoselective synthesis, for example by carrying out the process according to the invention using starting materials having correspondingly suitable stereochemistry. In each case it is advantageous to isolate or synthesise the biologically more active isomer, where the individual components have different biological activity. The compounds of formula (I) may also be obtained in the form of their hydrates and/or may include other solvents, for example solvents which may have been used for the crystallisation of compounds in solid form. The invention relates to all those embodiments of the process according to which a compound obtainable as starting material or intermediate at any stage of the process is used as starting material and all or some of the remaining steps are carried out, or in which a starting material is used in the form of a derivative and/or a salt and/or its diastereomers, or, especially, is formed under the reaction conditions. For instance compounds of formula (I) bearing a functional group or a protecting group, preferably in the 5-position, can be used as starting materials for the preparation of further compounds of formula (I). For such manipulations methods known to the person skilled in the art can be applied. In the processes of the present invention it is preferable to use those starting materials and intermediates which result in the compounds of formula (I) that are especially preferred. The invention relates especially to the preparation processes described in Examples A1.1 to A8.1. In the area of pest control, the compounds of formula (I) according to the invention are active ingredients exhibiting valuable preventive and/or curative activity with a very advantageous biocidal spectrum and a very broad spectrum, even at low rates of concentration, while being well tolerated by warm-blooded animals, fish and plants. They are, surprisingly, equally suitable for controlling both plant pests and ecto- and endo-parasites in humans and more especially in productive livestock, domestic animals and pets. They are effective against all or individual development stages of normally sensitive animal pests, but also of resistant animal pests, such as insects, preferably of the orders Lepidoptera; Coleoptera, Homoptera, Orthoptera, Isoptera, Psocoptera, Anoplura, Mallophaga, Thysanoptera; Heteroptera, Siphonaptera, Hymentoptera and Thysanura, and representatives of the order Acarina, nematodes, cestodes and trematodes, while at the same time protecting useful organisms. The said animal pests especially include, for example, those mentioned in European Patent Application EP-A-736 252, page 5, line 55, to page 6, line 55. The pests mentioned therein are therefore included by reference in the subject matter of the present invention. The insecticidal or acaricidal activity of the active ingredients according to the invention may manifest itself directly, i.e. in the mortality of the pests, which occurs immediately or only after some time, for example during moulting, or indirectly, for example in reduced oviposition and/or hatching rate, good activity corresponding to a mortality of at least 50 to 60%. It is also possible to control pests of the class Nematoda using the compounds according to the invention. Such pests include, for example, root knot nematodes, cyst-forming nematodes and also stem and leaf nematodes; especially of Heterodera spp., e.g. Heterodera schachtii, Heterodora avenae and Heterodora trifolii; Globodera spp., e.g. Globodera rostochiensis; Meloidogyne spp., e.g. Meloidogyne incognita and Meloidogyne javanica; Radopholus spp., e.g. Radopholus simiis; Pratylenchus, e.g. Pratylenchus neglectans and Pratylenchus penetrans; Tylenchulus, e.g. Tylenchulus semipenetrans; Longidorus, Trichodorus, Xiphinema, Ditylenchus, Apheenchoides and Anguina; insbesondere Meloidogyne, e.g. Meloidogyne incognita, and Heterodera, e.g. Heterodera glycines. An especially important aspect of the present invention is the use of the compounds of formula (I) according to the invention in the protection of plants against parasitic feeding pests. The compounds according to the invention can be used to control, i.e. to inhibit or destroy, pests of the mentioned type occurring on plants, especially on useful plants and ornamentals in agriculture, in horticulture and in forestry, or on parts of such plants, such as the fruits, blossoms, leaves, stems, tubers or roots, while in some cases plant parts that grow later are still protected against those pests. Target crops include especially cereals, such as wheat, barley, rye, oats, rice, maize and sorghum; beet, such as sugar beet and fodder beet; fruit, e.g. pomes, stone fruit and soft fruit, such as apples, pears, plums, peaches, almonds, cherries and berries, e.g. strawberries, raspberries and blackberries; leguminous plants, such as beans, lentils, peas and soybeans; oil plants, such as rape, mustard, poppy, olives, sunflowers, coconut, castor oil, cocoa and groundnuts; cucurbitaceae, such as marrows, cucumbers and melons; fibre plants, such as cotton, flax, hemp and jute; citrus fruits, such as oranges, lemons, grapefruit and mandarins; vegetables, such as spinach, lettuce, asparagus, cabbages, carrots, onions, tomatoes, potatoes and paprika; lauraceae, such as avocado, cinnamon and camphor; and tobacco, nuts, coffee, aubergines, sugar cane, tea, pepper, vines, hops, bananas, natural rubber plants and ornamentals. Further areas of use of the compounds according to the invention are the protection of stored goods and storerooms and the protection of raw materials, and also in the hygiene sector, especially the protection of domestic animals and productive livestock against pests of the mentioned type, more especially the protection of domestic animals, especially cats and dogs, from attack by fleas, ticks and nematodes. The invention therefore relates also to pesticidal compositions, such as emulsifiable concentrates, suspension concentrates,
{'app_number': None, 'application_number': '<application-reference appl-type="utility">\n<document-id>\n<country>US</country>\n<doc-number>10543637</doc-number>\n<date>20040130</date>\n</document-id>\n</application-reference>', 'doc_number': None, 'publication_number': '<publication-reference>\n<document-id>\n<country>US</country>\n<doc-number>20060140997</doc-number>\n<kind>A1</kind>\n<date>20060629</date>\n</document-id>\n</publication-reference>', 'source_file': './application/2006/ipa060629.xml', 'source_data': 'USPTO-Application'}